| Filing Date |
Description |
| 2012-09-14 |
The Company has an existing $5.0 million loan facility with Comerica pursuant to the Agreement, which amount has been fully advanced. The Amendment extends the interest-only payment period for an
additional twelve months, through September 23, 2013, ... |
| 2012-09-14 |
The Company has an existing $5.0 million loan facility with Comerica pursuant to the Agreement, which amount has been fully advanced. The Amendment extends the interest-only payment period for an
additional twelve months, through September 23, 2013, ... |
| 2012-08-28 |
On August 23, 2012, the Company also entered into a Volume Discount Program
Addendum with Atherotech, effective as of August 20, 2012 (the “Discount Addendum”), which amends the Purchase Agreement to provide for a limited term discount to A ... |
| 2012-05-21 |
The 2012 Annual Meeting of Stockholders (the “2012 Annual Meeting”) of diaDexus, Inc. (the “Company”) was held
pursuant to notice at 1:00 p.m. Pacific Daylight Time on May 17, 2012 at the Company’s principal executive offices ... |
| 2012-05-15 |
The foregoing is only a summary of the material terms of the Purchase Agreement, does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in
its entirety by reference to the Purchase Agree ... |
| 2012-03-22 |
On March 16, 2012, the Company also entered into a Rebate Addendum with HDL, effective as of March 1, 2012 (the “Rebate Addendum”), which amends the Purchase Agreement to provide for a
limited term rebate to HDL for increases in its purchas ... |
| 2012-03-15 |
The information furnished pursuant to this Item 2.02 of this
report, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to t ... |
| 2012-01-18 |
Dr. Viret,
age 46, joins the Company from XDx, Inc., a privately held molecular diagnostics company, where he has served as Chief Financial Officer since December 2009. From March 2009 to December 2009, Dr. Viret served as the President of JV Consult ... |
| 2012-01-09 |
The information furnished
pursuant to this Item 2.02 of this report, including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act ... |
| 2011-11-09 |
The information furnished pursuant to this Item 2.02 of this report, including
the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to t ... |
